Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) EPS (Basic) (2022 - 2026)

TriSalus Life Sciences has reported EPS (Basic) over the past 5 years, most recently at $0.03 for Q1 2026.

  • For Q1 2026, EPS (Basic) rose 107.69% year-over-year to $0.03; the TTM value through Mar 2026 reached -$1.32, down 17.86%, while the annual FY2025 figure was -$1.84, 40.46% down from the prior year.
  • EPS (Basic) for Q1 2026 was $0.03 at TriSalus Life Sciences, up from -$0.12 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.09 in Q1 2022 and troughed at -$79.38 in Q4 2022.
  • A 5-year average of -$8.58 and a median of -$0.39 in 2025 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): crashed 44900.0% in 2023 and later soared 107.69% in 2026.
  • Year by year, EPS (Basic) stood at -$79.38 in 2022, then soared by 98.68% to -$1.05 in 2023, then surged by 61.9% to -$0.4 in 2024, then soared by 70.0% to -$0.12 in 2025, then surged by 125.0% to $0.03 in 2026.
  • Business Quant data shows EPS (Basic) for TLSI at $0.03 in Q1 2026, -$0.12 in Q4 2025, and -$0.96 in Q3 2025.